Clinical Trial Update: Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated three docetaxel-based regimens plus bevacizumab, with or without trastuzumab, as adjuvant therapy for breast cancer to assess safet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• HERCEPTIN (trastuzumab)
• Taxotere (docetaxel)

Snippet

Sponsor: Sanofi | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-09-14